Citius Pharmaceuticals, Inc.
CTXR
$0.85
$0.000.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.76% | -66.00% | -99.79% | -94.59% | -87.72% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 169.53% | -- | -- | -- | -- |
| Prepaid Expenses | -48.31% | -86.99% | -66.62% | -63.82% | -65.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 96.44% | -12.12% | -14.83% | -35.03% | -58.63% |
|
|
|||||
| Total Current Assets | 96.44% | -12.12% | -14.83% | -35.03% | -58.63% |
| Net Property, Plant & Equipment | 232.53% | 193.66% | 161.37% | -52.73% | -46.00% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 56.23% | 56.23% | 56.23% | 56.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 12.25% | 31.50% | 33.92% | 23.93% | 12.59% |
|
|
|||||
| Total Accounts Payable | 177.92% | 506.87% | 250.93% | 178.17% | 68.32% |
| Total Accrued Expenses | 233.16% | 442.95% | 838.81% | 226.39% | -14.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -63.44% | -51.32% | -36.83% | -8.66% | 10.58% |
| Total Finance Division Other Current Liabilities | -20.25% | -- | -- | -- | -- |
| Total Other Current Liabilities | -20.25% | -- | -- | -- | -- |
| Total Current Liabilities | 25.41% | 1,148.59% | 1,095.08% | 703.15% | 519.74% |
|
|
|||||
| Total Current Liabilities | 25.41% | 1,148.59% | 1,095.08% | 703.15% | 519.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3,303.29% | 808.77% | 442.18% | -- | -91.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.74% | 14.26% | 12.71% | 11.08% | 9.38% |
| Total Liabilities | 25.52% | 456.30% | 438.94% | 329.20% | 249.35% |
|
|
|||||
| Common Stock & APIC | 12.86% | 7.11% | 9.00% | 7.94% | 7.27% |
| Retained Earnings | -18.59% | -21.13% | -23.36% | -23.14% | -24.13% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.61% | -24.07% | -23.57% | -22.81% | -22.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.61% | -24.07% | -23.57% | -22.81% | -22.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 147.92% | 316.79% | 385.74% | 484.84% | 570.29% |
| Total Equity | 4.62% | -21.70% | -20.50% | -19.24% | -18.95% |
|
|
|||||